The equation of state of hadron resonance gas at finite temperature and baryon density is calculated taking into account finite-size effects within the excluded volume model. Contributions of known hadrons with masses up to 2 GeV are included in the zero-width approximation. Special attention is paid to the role of strange hadrons in the system with zero total strangeness. A densitydependent mean field is added to guarantee that the nuclear matter has a saturation point and a liquid-gas phase transition. The deconfined phase is described by the bag model with lowest order perturbative corrections. The phase transition boundaries are found by using the Gibbs conditions with the strangeness neutrality constraint. The sensitivity of the phase diagram to the hadronic excluded volume and to the parametrization of the mean-field is investigated. The possibility of strangeness-antistrangeness separation in the mixed phase is analyzed. It is demonstrated that the peaks in the K/π and Λ/π excitation functions observed at low SPS energies can be explained by a nonmonotonous behavior of the strangeness fugacity along the chemical freeze-out line.
The most general representation of the functions of the relative phase permeabilities for porous media is written explicitly. The relations proposed for the relative phase permeabilities generalize those obtained earlier for media with transversely-isotropic and orthotropic percolation properties [1,2] which can now be obtained as a particular case. A laboratory measurement technique for finding the percolation properties and determining the absolute and phase permeabilities for media with different types of anisotropy is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.